MedTrace Logo

The Effect of Diet on Disease Activity and Symptoms in Patients With Ulcerative Colitis

NCT03053713 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 28

Last updated 2022-05-23

No results posted yet for this study

Summary

The Mediterranean Diet Pattern (MDP) has been shown to have beneficial effects on the intestinal bacteria and the immune system in diseases like cancer and diabetes. The aim of this study is to determine if a MDP will have an impact on symptoms, intestinal bacteria and the immune system in Ulcerative Colitis (UC). Symptoms, blood and stool will be examined to determine if the MDP results in changes to the intestinal bacteria or immune system.

Conditions

Interventions

BEHAVIORAL

Mediterranean diet pattern

Subjects assigned to the Mediterranean diet pattern arm will receive nutrition advice from a Registered Dietitian (RD). The RD will meet with the subjects (in-person) to provide diet education at randomization, week 3 and week 6 of the intervention. Phone and e-mail follow-up will occur at week 2 and week 9 to provide cooking tips, recipes, videos and answer questions.

BEHAVIORAL

Habitual diet (control)

Subjects assigned to follow their habitual group will be instructed to make no changes to their diet over 12 weeks.

Sponsors & Collaborators

  • Canadian Foundation for Dietetic Research (CFDR)

    collaborator OTHER

  • University of British Columbia

    lead OTHER

Principal Investigators

  • Deanna L Gibson, PhD · University of British Columbia- Okanagan

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-04
Primary Completion
2021-08-30
Completion
2021-08-30

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03053713 on ClinicalTrials.gov